- Moneycontrol /
- Market /
- Pharmaceuticals /
- QUARTERLY RESULTS
BSE Live
Jul 16, 16:00Prev. Close
188.30
Open Price
189.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jul 16, 15:55Prev. Close
188.60
Open Price
188.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Quarterly Results of Unichem Laboratories (in Rs. Cr.) | Mar '20 | Dec '19 | Sep '19 | Jun '19 | Mar '19 | |
| Net Sales/Income from operations | 216.07 | 231.20 | 225.10 | 232.52 | 277.08 | |
| Other Operating Income | -- | -- | -- | -- | -- | |
| Total Income From Operations | 216.07 | 231.20 | 225.10 | 232.52 | 277.08 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 86.31 | 110.92 | 102.18 | 100.79 | 104.05 | |
| Purchase of Traded Goods | 0.38 | 0.09 | 0.21 | 0.36 | 0.11 | |
| Increase/Decrease in Stocks | -6.65 | -14.75 | 4.19 | -1.29 | 12.94 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 53.35 | 50.82 | 52.12 | 48.86 | 48.07 | |
| depreciat | 19.11 | 17.26 | 17.86 | 16.86 | 17.72 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 93.65 | 109.82 | 102.21 | 101.91 | 116.71 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -30.09 | -42.96 | -53.68 | -34.97 | -22.53 | |
| Other Income | 19.13 | 23.01 | 29.05 | 27.98 | 22.56 | |
| P/L Before Int., Excpt. Items & Tax | -10.96 | -19.95 | -24.63 | -6.99 | 0.03 | |
| Interest | 0.59 | 0.42 | 0.23 | 0.05 | 0.41 | |
| P/L Before Exceptional Items & Tax | -11.54 | -20.37 | -24.86 | -7.03 | -0.38 | |
| Exceptional Items | -- | -- | -- | -- | -- | |
| P/L Before Tax | -11.54 | -20.37 | -24.86 | -7.03 | -0.38 | |
| Tax | 0.00 | -- | -- | -7.50 | -4.08 | |
| P/L After Tax from Ordinary Activities | -11.55 | -20.37 | -24.86 | 0.46 | 3.69 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | 6.25 | |
| Net Profit/(Loss) For the Period | -11.55 | -20.37 | -24.86 | 0.46 | 9.94 | |
| Equity Share Capital | 14.08 | 14.08 | 14.08 | 14.08 | 14.08 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | -1.65 | -2.89 | -3.53 | 0.07 | 1.41 | |
| Diluted EPS | -1.65 | -2.89 | -3.53 | 0.07 | 1.41 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | -1.65 | -2.89 | -3.53 | 0.07 | 1.41 | |
| Diluted EPS. | -1.65 | -2.89 | -3.53 | 0.07 | 1.41 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
07.07.2020
Unichem Laboratories gets USFDA nod to market muscle spasm tablets
22.06.2020
Unichem Labs Standalone March 2020 Net Sales at Rs 216.07 crore, down 22.02% Y-o-Y
22.06.2020
Unichem Labs Consolidated March 2020 Net Sales at Rs 320.23 crore, down 14.43% Y-o-Y
24.02.2020
Unichem Labs share price jumps 12% on no observations from USFDA for Roha unit
22.06.2020
Unichem Labs Standalone March 2020 Net Sales at Rs 216.07 crore, down 22.02% Y-o-Y
22.06.2020
Unichem Labs Consolidated March 2020 Net Sales at Rs 320.23 crore, down 14.43% Y-o-Y
07.02.2020
Unichem Labs Consolidated December 2019 Net Sales at Rs 297.05 crore, down 2.12% Y-o-Y
04.02.2020
Unichem Labs Consolidated December 2019 Net Sales at Rs 297.05 crore, down 2.12% Y-o-Y
